Manuel B. Garcia

Manuel B. Garcia serves as the Senior Director for Educational Technology and Digital Learning at FEU Institute of Technology, Manila, Philippines. Read More

Contact Info

1607, FEU Tech Building,
P. Paredes St, Sampaloc,
Manila, Philippines
mbgarcia@feutech.edu.ph

Follow Me

Can Lack of Real-World Evidence Be a Research Gap?

An intervention may perform well under research conditions while its performance in routine use remains uncertain. Learn when lack of real-world evidence creates a genuine research gap.

260
Lack of Real-World Evidence Guide 260 of 533
01 · The Question

What If Something Works in a Study but We Do Not Know What Happens in Routine Use?

Some research questions appear well answered until you examine the conditions under which the evidence was produced.

An intervention may have been tested with carefully selected participants, specially trained personnel, unusually close monitoring, strong adherence support, additional resources, or procedures that differ substantially from ordinary practice. Under those conditions, the results may be convincing.

But what happens when the intervention leaves the research environment and encounters routine users, ordinary workloads, imperfect adherence, variable resources, and everyday implementation constraints?

Can the lack of evidence under those conditions constitute a research gap?

02 · The Short Answer

Yes, When Controlled Evidence Does Not Resolve What Happens Under Routine Conditions

In Brief

Lack of real-world evidence can constitute a genuine research gap when existing studies establish what happens under controlled, selected, or research-intensive conditions but provide insufficient evidence about outcomes, implementation, safety, use, or effectiveness under conditions resembling actual practice.

Real-world research is not automatically superior to controlled research. The two may answer different questions. A meaningful gap exists when decisions require evidence about routine use that the existing evidence base cannot adequately provide.

03 · What You Need to Know

When Does Missing Real-World Evidence Become a Genuine Research Gap?

First, “Real-World Evidence” Has a Specific Meaning in Some Fields

The phrase real-world evidence is used broadly across disciplines, but it also has formal meanings in regulatory health research. The U.S. Food and Drug Administration distinguishes real-world data from real-world evidence and maintains a dedicated program concerning their use in healthcare decision-making.

In regulatory contexts, real-world data concern routinely collected information relating to patient health status or healthcare delivery, while real-world evidence concerns clinical evidence about the use and potential benefits or risks of a medical product derived from analysis of real-world data.

Outside health research, researchers often use real-world evidence more loosely to refer to evidence generated under routine, naturally occurring, operational, or practice conditions. If you are working outside the regulatory health context, define what you mean rather than assuming the phrase has one universal disciplinary definition.

The Underlying Question Is Often “Can It Work?” Versus “Does It Work Here?”

Controlled studies can be designed to determine whether an intervention produces an effect under conditions that give it a strong opportunity to do so. Other studies are designed to inform decisions about what happens when the intervention is used under ordinary conditions.

PRECIS-2 describes this distinction as a continuum between explanatory and pragmatic trial intentions. Explanatory trials tend toward ideal conditions, whereas pragmatic trials are designed to support decisions under usual conditions. The framework emphasizes that these are not two mutually exclusive boxes. Trial features can be more or less pragmatic across several domains.

More explanatory question Can the intervention produce the intended effect under conditions designed to demonstrate its effect clearly?
More pragmatic question What happens when the intervention is delivered under conditions resembling those in which it would ordinarily be used?

Both questions can be scientifically valuable. Problems arise when evidence answering the first is treated as though it completely answers the second.

“Real World” Is Not a Single Place

A hospital is real. A laboratory is real. A university research site is real. The phrase does not mean that controlled research somehow occurs outside reality.

The useful distinction concerns how closely study conditions resemble the circumstances in which the intervention, policy, technology, or practice is intended to be used.

PRECIS-2 makes this concrete through nine domains: eligibility, recruitment, setting, organization, flexibility of delivery, flexibility of adherence, follow-up, primary outcome, and primary analysis. A study can be pragmatic in one domain and relatively explanatory in another.

This is a more defensible way to discuss real-world relevance than simply labeling one study "real world" and another "artificial."

Routine Conditions Can Change More Than the Effect Size

When an intervention moves into ordinary practice, many aspects of its performance may become important.

Question What real-world evidence may reveal
Effectiveness Whether expected benefits occur under ordinary conditions
Reach Who actually receives, adopts, or uses the intervention
Adherence Whether people use the intervention as intended without intensive research support
Implementation Whether organizations and practitioners can deliver the intervention routinely
Safety Whether harms or uncommon problems become apparent in broader use
Sustainability Whether use continues after initial implementation support ends
Resource requirements Whether routine delivery demands more time, expertise, infrastructure, or cost than expected

A real-world evidence gap should specify which of these uncertainties matters. "There is little real-world research" is much less informative than explaining that effectiveness under routine staffing and adherence conditions remains uncertain.

A Controlled Study Is Not Inferior Because It Is Controlled

Controlled conditions can reduce noise, isolate causal effects, standardize delivery, and answer questions that would be difficult to resolve in routine practice. Those are strengths when they match the research objective.

Pragmatic designs involve their own trade-offs. Routine conditions may introduce heterogeneity, imperfect adherence, variation in implementation, missing data, and confounding that complicate interpretation.

Watch Out

Do not frame real-world research as the methodologically superior stage that replaces controlled research. The relevant issue is fitness for purpose: which design and data are needed to answer the question at hand?

Real-World Evidence Is Not the Same as Observational Evidence

Real-world data are often observational, such as electronic health records, registries, administrative records, routine platform data, or other information generated outside a traditional trial. But observational and real-world are not synonyms.

Randomized trials can be highly pragmatic and embedded within routine practice. Conversely, an observational study can use highly selected data or analytic procedures that do not necessarily make its conclusions broadly applicable.

Study design and degree of pragmatism should therefore be considered separately.

Real-World Data Are Not Automatically High-Quality Data

Routine data can offer large samples and reflect actual practice, but they were often collected for purposes other than the research question now being asked.

Important variables may be missing, inconsistently recorded, measured differently across sites, or affected by changes in systems and practice. Confounding and selection can complicate causal interpretation in observational analyses. Data provenance, completeness, measurement quality, and fitness for use therefore require careful evaluation.

More data do not automatically mean better evidence. That familiar methodological nuisance has survived the era of big data quite comfortably.

A Real-World Gap Can Overlap With a Missing Setting

If an intervention has been tested only in specialist research centers and is intended for routine community use, the literature may contain both a missing-setting gap and a lack of real-world evidence.

The distinction lies in emphasis. A missing-setting gap asks whether evidence applies in a particular environment that is underrepresented. A real-world evidence gap asks more broadly whether findings hold under the ordinary conditions of actual implementation and use.

Sometimes the same study can address both.

Real-World Evidence Can Also Test External Validity

A tightly controlled study may deliberately restrict participants, providers, or settings to improve internal validity or answer a focused explanatory question. Those choices can leave uncertainty about applicability beyond the study conditions.

Real-world studies can provide evidence about whether findings extend to broader users and routine environments. That does not guarantee generalizability everywhere. The target population and intended context still need to be specified.

If the research product is specifically a prediction model or algorithm, the more precise issue may instead be lack of external validation.

Implementation Failure and Intervention Failure Are Not the Same

Suppose an intervention performs poorly in routine practice. One interpretation is that the intervention itself is ineffective. Another is that it was rarely delivered as intended, users could not access it, staff lacked resources, or organizations could not sustain it.

Real-world research can help distinguish these possibilities, especially when outcome data are accompanied by evidence about implementation and exposure.

This matters because an intervention that fails under routine conditions may require adaptation, additional implementation support, or abandonment. Those are different conclusions, and outcome data alone may not distinguish them.

Routine Use Can Reveal Effects That Controlled Studies Are Poorly Positioned to Detect

Research conducted under selected conditions may involve relatively homogeneous participants, close monitoring, high adherence, or limited follow-up. Wider implementation can expose an intervention to more diverse users and circumstances.

That may reveal heterogeneity of effects, implementation problems, uncommon adverse outcomes, or resource demands that were not apparent during earlier studies.

Again, this does not make routine data intrinsically more truthful. It makes them informative about a different set of conditions.

How Do You Establish That Real-World Evidence Is Actually Missing?

First identify what kind of evidence already exists. Do not assume that every randomized trial is explanatory or that every observational study is real-world. Examine eligibility criteria, recruitment, setting, organization, delivery, adherence support, follow-up, outcomes, and analysis.

Search terms may include pragmatic, effectiveness, routine practice, usual care, implementation, registry, administrative data, electronic records, practice-based research, naturalistic, and discipline-specific terminology.

Then specify the unresolved question. A defensible statement might be: "Controlled trials demonstrate efficacy under intensive implementation support, but evidence concerning effectiveness and sustained use under routine institutional conditions remains limited."

That is considerably stronger than claiming that the intervention has never been studied in the real world.

04 · A Practical Example

When an Educational Technology Leaves the Research Trial

Hypothetical Example

AI Tutoring Under Routine University Conditions

Suppose several controlled studies show that an AI tutoring system improves student performance. In those studies, participants receive orientation, instructors receive specialized training, technical support is readily available, and researchers monitor student use closely.

What is already known The system can improve learning outcomes when implemented with substantial support under structured research conditions.
What changes in routine use Instructors receive ordinary institutional support, students choose when and how much to use the system, technical assistance competes with other demands, and researchers do not continually encourage adherence.
What remains uncertain The existing trials do not establish whether the intervention retains sufficient reach, use, and effectiveness under these routine conditions.
What the new study examines The university implements the system through its ordinary processes while researchers evaluate adoption, patterns of use, implementation, and educational outcomes.
What the evidence adds The study shows whether promising efficacy evidence translates into useful performance under conditions closer to ordinary institutional practice.

The research question is no longer simply whether AI tutoring can improve learning. It concerns what happens when the intervention must function without the unusually supportive conditions of the original studies.

05 · What Researchers Often Get Wrong

Common Mistakes When Claiming a Real-World Evidence Gap

Misconception

Randomized Trials Are Not Real-World Evidence

That is too simplistic. Randomized trials can be designed pragmatically and embedded in routine practice. Randomization concerns treatment allocation; pragmatism concerns how closely design choices match the conditions in which results are intended to be used.

Misconception

Observational Data Are Automatically Real-World and Generalizable

Observational data may arise from routine practice, but that does not guarantee representativeness, measurement quality, causal validity, or applicability to every target population.

Misconception

A Controlled Trial Is Artificial and Therefore Less Useful

Controlled designs may be exactly what is needed to answer efficacy or causal questions. The problem arises only when evidence generated for one purpose is expected to answer a different question about routine implementation or effectiveness.

Misconception

Using a Large Existing Dataset Automatically Produces Real-World Evidence

Dataset size does not establish fitness for purpose. Researchers still need to evaluate how variables were generated, what is missing, who is represented, how exposures and outcomes were measured, and what biases may affect the intended inference.

Misconception

If Effectiveness Is Lower in Routine Practice, the Original Trial Was Wrong

No. The studies may be answering different questions under different conditions. Lower effectiveness can reflect adherence, reach, implementation, case mix, resources, or other differences between controlled and routine use.

Misconception

“Real World” Is Enough Description for a Research Design

It is not. Describe the participants, setting, data source, delivery conditions, comparison, follow-up, outcome measurement, and analytic design. Readers need to know what makes the evidence relevant to routine practice.

06 · What This Means for You

How to Decide Whether Lack of Real-World Evidence Justifies Your Study

Start with the decision that existing research cannot adequately inform. Then identify which features of routine use are missing from the evidence.

A simple decision framework

If efficacy is established under controlled conditions but routine effectiveness remains uncertain
A pragmatic or otherwise practice-oriented study may address a meaningful evidence gap.
If implementation conditions differ substantially from those in previous studies
Examine whether those differences could affect reach, adherence, delivery, outcomes, or sustainability.
If routine data already provide extensive high-quality evidence relevant to the decision
Do not claim a real-world gap simply because the evidence was generated differently from your preferred design.
If the main uncertainty concerns one underrepresented environment
A setting gap may be more precise than a broad real-world evidence gap.
If your proposed routine data cannot support the intended causal or measurement claims
Do not trade methodological adequacy for the label "real world." Redesign the study or narrow the claim.

A persuasive real-world evidence gap therefore specifies what controlled evidence already establishes, which routine conditions remain inadequately represented, why those conditions matter, and what decision better practice-based evidence would support.

07 · A Quick Checklist

Before Claiming Lack of Real-World Evidence as Your Research Gap

Before writing the gap statement, check:
Define what "real-world" means for your discipline and specific research question.
Identify which existing studies are explanatory, pragmatic, observational, or otherwise relevant rather than classifying them by design label alone.
Specify which routine conditions differ from those represented in the existing evidence.
Explain whether the unresolved question concerns effectiveness, reach, adherence, implementation, safety, sustainability, resources, or another consequential issue.
Evaluate whether proposed real-world data are sufficiently complete, accurate, relevant, and fit for the intended analysis.
Distinguish a real-world evidence gap from a missing setting, external-validation, or methodological gap.
Avoid assuming that routine practice evidence is inherently superior to controlled evidence.
State what practical or scientific decision becomes better informed if the gap is addressed.
08 · Frequently Asked Questions

Frequently Asked Questions About Real-World Evidence Gaps

What is the difference between real-world data and real-world evidence?

In the FDA regulatory context, real-world data are routinely collected data relating to patient health status or healthcare delivery. Real-world evidence is clinical evidence about the use and potential benefits or risks of a medical product derived from analysis of real-world data. Other disciplines may use the terminology more broadly.

Is real-world evidence always observational?

No. Real-world evidence can be generated through several designs, and randomized studies can be embedded in routine practice. Pragmatism and randomization describe different features of a study.

What is the difference between efficacy and effectiveness?

In broad terms, efficacy concerns whether an intervention produces benefit under comparatively controlled or ideal conditions, while effectiveness concerns performance under conditions closer to routine practice. The exact terminology and boundary vary across fields and study designs.

Does a pragmatic trial have to use existing routine data?

No. Pragmatism concerns whether design choices align with the conditions in which results are intended to be used. A pragmatic trial can collect research-specific data while still resembling usual practice in important domains.

Can electronic health records or learning-management-system logs provide real-world evidence?

Potentially. Such data may reflect routine activity, but researchers still need to evaluate their provenance, completeness, measurement quality, population coverage, and fitness for the intended inference.

Can real-world evidence contradict randomized trial evidence?

Yes. Differences may reflect populations, adherence, implementation, measurement, confounding, settings, or other design features. Disagreement should prompt investigation rather than an automatic conclusion that one evidence source is correct and the other is wrong.

Does every intervention eventually need a real-world study?

Not necessarily. The value depends on how the intervention will be used, how different routine conditions are from existing research conditions, the consequences of uncertainty, and whether existing evidence already supports the relevant decision adequately.

09 · The Bottom Line

Evidence That Something Can Work Is Not Always Evidence of What Happens in Routine Use

The Bottom Line

Lack of real-world evidence can be a genuine research gap when existing studies establish outcomes under controlled or selected conditions but leave consequential uncertainty about effectiveness, implementation, safety, use, or sustainability under conditions resembling actual practice.

Do not treat "real world" as a synonym for better research. Identify the decision that routine evidence needs to inform, specify which ordinary conditions are missing from the current evidence base, and choose a design and data source capable of answering that question rigorously.

10 · Sources and Further Reading

Sources and Further Reading

11 · Cite this Guide

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.

Has the Field Guide helped your research?

If a guide helped clarify a question, inform a research decision, or move your work forward, I would love to hear about your experience. Your story may also help other researchers discover the Field Guide.

Share Your Experience
Takes only a few minutes